ScoreWhy is Bristol Myers Squibb Co. ?
1
Healthy long term growth as Net Sales has grown by an annual rate of 6.47% and Operating profit at 23.31%
2
The company has declared positive results in Mar'2025 after 4 consecutive negative quarters
- OPERATING CASH FLOW(Y) Highest at USD 15,901 MM
- ROCE(HY) Highest at 29.31%
- DIVIDEND PER SHARE(HY) Highest at USD 3.15
3
With ROCE of 19.69%, it has a fair valuation with a 3.08 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -9.62%, its profits have risen by 1.8% ; the PEG ratio of the company is 10.5
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -9.62% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Bristol Myers Squibb Co. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Bristol Myers Squibb Co. for you?
Low Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Bristol Myers Squibb Co.
-4.72%
0.70
29.05%
S&P 500
20.78%
0.70
20.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.83%
EBIT Growth (5y)
24.18%
EBIT to Interest (avg)
5.76
Debt to EBITDA (avg)
1.96
Net Debt to Equity (avg)
2.19
Sales to Capital Employed (avg)
0.73
Tax Ratio
10.99%
Dividend Payout Ratio
71.98%
Pledged Shares
0
Institutional Holding
82.46%
ROCE (avg)
13.51%
ROE (avg)
33.03%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
6.85
EV to EBIT
12.45
EV to EBITDA
8.19
EV to Capital Employed
2.92
EV to Sales
3.25
PEG Ratio
NA
Dividend Yield
86.81%
ROCE (Latest)
23.42%
ROE (Latest)
51.19%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
NET PROFIT(9M)
At USD 8,865.82 MM has Grown at 57.05%
ROCE(HY)
Highest at 40.53%
DIVIDEND PER SHARE(HY)
Highest at USD 3.33
INTEREST COVERAGE RATIO(Q)
Highest at 1,079.63
DIVIDEND PAYOUT RATIO(Y)
Highest at 118.29%
RAW MATERIAL COST(Y)
Fallen by -1.1% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at 197.4 %
DEBTORS TURNOVER RATIO(HY)
Highest at 3.33 times
NET SALES(Q)
Highest at USD 12,502 MM
-3What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD 12,202 MM
EPS(Q)
Lowest at USD 0.53
Here's what is working for Bristol Myers Squibb Co.
Interest Coverage Ratio
Highest at 1,079.63
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Dividend per share
Highest at USD 3.33 and Grown
In each year in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (USD)
Net Profit
At USD 8,865.82 MM has Grown at 57.05%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Net Sales
Highest at USD 12,502 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Debt-Equity Ratio
Lowest at 197.4 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 3.33 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Dividend Payout Ratio
Highest at 118.29%
in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Raw Material Cost
Fallen by -1.1% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 1,032 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Bristol Myers Squibb Co.
Operating Cash Flow
Lowest at USD 12,202 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
EPS
Lowest at USD 0.53
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
Non Operating Income
Highest at USD 0.5 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
